Market Overview:
The global Vibrio cholerae nucleic acid test kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cholera and other waterborne diseases, growing demand for rapid diagnosis, and technological advancements in nucleic acid testing (NAT) technology. The global Vibrio cholerae nucleic acid test kit market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dry PCR and fluorescence PCR. The fluorescence PCR segment is expected to grow at a higher CAGR than the dry PCR segment during the forecast period owing to its advantages such as high sensitivity and specificity, short turnaround time, low cost per assay point compared with wet-lab methods such as real-time polymerase chain reaction (PCR),and ease of use. On the basis of application,the global Vibrio cholerae nucleic acid test kit market is divided into hospital laboratories and clinic laboratories.
Product Definition:
A Vibrio cholerae nucleic acid test kit is a diagnostic tool used to detect the presence of the Vibrio cholerae bacterium in a sample. The test kit can be used to diagnose cholera, an illness caused by the bacteria. The test kit is also used to screen for and monitor outbreaks of cholera.
Dry PCR:
Dry PCR, also known as DNA-based PCR (Nucleic Acid Based Test) is a new and innovative technique that uses dry reagents to detect the presence of specific DNA sequences in the target sequence. The major advantage of this technique is that it does not require any external cooling mechanism which makes it more reliable than other conventional PCR techniques.
This technology has been used for detecting various infectious diseases such as Cholera, influenza B.
Fluorescence PCR:
Fluorescence Polymerase Chain Reaction (PCR) is a technique that involves the use of fluorescent dyes to amplify a specific region of DNA. The method allows for more sensitivity in detecting low-frequency variations and helps reduce the number of false positives. In addition, it also has higher specificity than other conventional PCR techniques as it eliminates the influence of environmental factors such as temperature, pH, and ionic strength on results.
Application Insights:
Based on application, the global Vibrio cholerae nucleic acid test kit market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to an increase in number of patients with cholera across the globe. Moreover, an increase in spending on diagnostics related to Vibrio cholerae is also expected to drive growth over the forecast period.
The other segments such as clinics and laboratories are anticipated to witness significant growth during the forecast period due to rise awareness about early diagnosis coupled with high demand for rapid testing solutions that can assist healthcare professionals meet rising patient expectations regarding faster results delivery timeframes. In addition, a decrease in cost associated with these tests will further boost its adoption rate among various organizations including health departments and laboratories across countries globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high disease prevalence rate, and increasing R&D activities for new diagnostic approaches are some of the major factors responsible for its continued dominance over the forecast period. Moreover, rising awareness among people about Vibrio cholerae infection and diarrheal diseases is also expected to drive this regional market during the same period.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast years owing to continuous improvements in healthcare facilities especially in developing countries such as India and China along with growing R&D initiatives undertaken by private companies as well as public institutes for novel diagnostics methods against Vibrio cholera infections. In addition, government programs focusing on improving water & sanitation infrastructure are also expected to contribute toward regional growth over the next eight years.
Growth Factors:
- Increasing incidence of cholera: The global incidence of cholera is increasing due to various factors such as changing demographics, environmental changes, and globalization. This is expected to drive the demand for Vibrio Cholerae Nucleic Acid Test Kits.
- Growing awareness about cholera: There is a growing awareness about the symptoms and prevention of cholera among people across the globe. This is likely to boost demand for Vibrio Cholerae Nucleic Acid Test Kits in the coming years.
- Technological advancements: The development of new and innovative technologies has led to the introduction of advanced diagnostic tests for detecting Vibrio Cholerae infections, which is expected to fuel market growth in the near future.
- Rising number of outbreaks: The number of outbreaks caused by Vibrio Cholerae has been increasing in recent years due to various reasons such as climate change, changing lifestyles, etc., This is anticipated to create a high demand for Vibrio Cholerae Nucleic Acid Test Kits in developed and developing countries alike over the forecast period.. 5) Increasing funding for research on cholera: Governments and private organizations are investing heavily in research on diagnostics and treatment methods for cholera infections, which is likely to propel market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Vibrio Cholerae Nucleic Acid Test Kit Market Research Report
By Type
Dry PCR, Fluorescence PCR
By Application
Hospital, Clinic
By Companies
Liferiver, Mole, Bioperfectus, Maternova, BioGerm, Abbott, HFBiotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Vibrio Cholerae Nucleic Acid Test Kit Market Report Segments:
The global Vibrio Cholerae Nucleic Acid Test Kit market is segmented on the basis of:
Types
Dry PCR, Fluorescence PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Liferiver
- Mole
- Bioperfectus
- Maternova
- BioGerm
- Abbott
- HFBiotech
Highlights of The Vibrio Cholerae Nucleic Acid Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry PCR
- Fluorescence PCR
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vibrio Cholerae Nucleic Acid Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Vibrio Cholerae Nucleic Acid Test Kit is a laboratory test that detects the presence of nucleic acid from Vibrio cholerae bacteria in a sample. This test can be used to determine whether someone has contracted cholera, or to help confirm the diagnosis of cholera if it is suspected.
Some of the major companies in the vibrio cholerae nucleic acid test kit market are Liferiver, Mole, Bioperfectus, Maternova, BioGerm, Abbott, HFBiotech.
The vibrio cholerae nucleic acid test kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vibrio Cholerae Nucleic Acid Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vibrio Cholerae Nucleic Acid Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vibrio Cholerae Nucleic Acid Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vibrio Cholerae Nucleic Acid Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vibrio Cholerae Nucleic Acid Test Kit Market Size & Forecast, 2020-2028
4.5.1 Vibrio Cholerae Nucleic Acid Test Kit Market Size and Y-o-Y Growth
4.5.2 Vibrio Cholerae Nucleic Acid Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry PCR
5.2.2 Fluorescence PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vibrio Cholerae Nucleic Acid Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vibrio Cholerae Nucleic Acid Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry PCR
9.6.2 Fluorescence PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry PCR
10.6.2 Fluorescence PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry PCR
11.6.2 Fluorescence PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry PCR
12.6.2 Fluorescence PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry PCR
13.6.2 Fluorescence PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vibrio Cholerae Nucleic Acid Test Kit Market: Competitive Dashboard
14.2 Global Vibrio Cholerae Nucleic Acid Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Liferiver
14.3.2 Mole
14.3.3 Bioperfectus
14.3.4 Maternova
14.3.5 BioGerm
14.3.6 Abbott
14.3.7 HFBiotech
